The mechanisms of melanoma metastasis have been the subject of extensive research for decades. Improved diagnostic and therapeutic strategies are...
Read More »An interferon-driven oxysterol-based defense against tumor-derived extracellular vesicles
Tumor-derived extracellular vesicles (TEV) “educate” healthy cells to promote metastases. Researchers from the University of Pennsylvania found that melanoma TEV downregulated type I interferon (IFN)...
Read More »Exosomes in melanoma – a role in tumor progression, metastasis and impaired immune system activity
Exosomes (Exo) are small vesicles produced by melanoma cells and the accessory cells of the tumor microenvironment. They emerge via both classical and direct pathways and actively participate in tumor colonisation of distant tissues. The proteins, nucleic acids, cytokines and ...
Read More »Immunoaffinity-based isolation of melanoma cell-derived exosomes from plasma of patients with melanoma
Tumour-derived exosomes (TEX) are a subset of extracellular vesicles (EVs) present in body fluids of patients with cancer. The role of this exosome subset in melanoma progression has been of interest ever since ex vivo studies of exosomes produced by ...
Read More »Melanoma exosomes can induce a pro-tumor macrophage activation phenotype
Macrophages are key participants in melanoma growth and survival. In general, macrophages can be classified as M1 or M2 activation phenotypes. Increasing evidence demonstrates that melanoma exosomes also facilitate tumor survival and metastasis. However, the role of melanoma exosomes in ...
Read More »Exosomes Derived From Natural Killer Cells Exert Therapeutic Effect in Melanoma
Exosomes are nanovesicles that are released from normal and tumor cells and are detectable in cell culture supernatant and human biological fluids. Although previous studies have explored exosomes released from cancer cells, little is understood regarding the functions of exosomes ...
Read More »Study using Biocartis’ liquid biopsy BRAF assay shows new option for retreatment of melanoma patients
Biocartis Group NV , an innovative molecular diagnostics company, today announces the publication in the renowned clinical oncology journal The Lancet Oncology of an important study[1] by Prof. Dr. Bart Neyns from the University Hospital in Brussels (Belgium). In this ...
Read More »Clinical Applications of NanoVelcro Rare-Cell Assays for Detection and Characterization of Circulating Tumor Cells
Liquid biopsy of tumor through isolation of circulating tumor cells (CTCs) allows non-invasive, repetitive, and systemic sampling of disease. Although detecting and enumerating CTCs is of prognostic significance in metastatic cancer, it is conceivable that performing molecular and functional characterization ...
Read More »Exosome Diagnostics Presents Data on Novel Platform for Disease- Specific Exosomes
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Exosome Diagnostics, Inc., the world’s only provider of a revolutionary liquid biopsy platform that enables analysis of both living and dying processes of disease states, thus aiming to reduce or eliminate the need for tissue biopsies, today announced ...
Read More »Adipocyte exosomes drive melanoma progression
New research has identified a novel mode of communication between adipocytes and cancer cells that regulates tumour aggressiveness. Adipocyte exosomes (ad-exos) purified from conditioned medium of 3T3-F442A mature adipocytes increased melanoma cell migration and invasion in vitro. Analysis of the ...
Read More »